Squarekids and Rotarix Co-administration in Japanese Infants

Phase 4, randomised, open-label trial of Squarekids subcutaneous injection syringe in diphtheria, Tetanus, pertussis and 1 more (2 arms), sponsored by GSK. Primary endpoints: Percentage of Subjects With Anti-diphtheria (Anti-D) Antibody Concentrations Greater Than or Equal to the Cut-off Value at Month 5, Percentage of Subjects With Anti-tetanus (Anti-T) Antibody Concentrations Greater Than or Equal to the Cut-off Value at Month 5 and 3 more. Started Sep 2016; status: completed.